The stock of Soleno Therapeutics Inc (NASDAQ:SLNO) last traded at $20.67, down -22.87% from the previous session.
Data from the available sources indicates that Soleno Therapeutics Inc (NASDAQ:SLNO) is covered by 3 analysts. The consensus rating among analysts is ‘Buy’. SLNO stock price is now 304.67% away from the 50-day moving average and 465.25% away from the 200-day moving average. The market capitalization of the company currently stands at $206.49M.
In total, 0 analysts have assigned it a hold rating, and 3 have given it a buy rating.
With the price target of $8, Guggenheim recently initiated with Buy rating for Soleno Therapeutics Inc (NASDAQ: SLNO).
In other news, PERCEPTIVE ADVISORS LLC, 10% Owner bought 200 shares of the company’s stock on Jun 06. The stock was bought for $1,186 at an average price of $5.93. Upon completion of the transaction, the 10% Owner now directly owns 2,207,753 shares in the company, valued at $45.63 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 05, 10% Owner PERCEPTIVE ADVISORS LLC bought 78,468 shares of the business’s stock. A total of $469,239 was incurred on buying the stock at an average price of $5.98. This leaves the insider owning 2,207,553 shares of the company worth $45.63 million. Insiders disposed of 430,071 shares of company stock worth roughly $8.89 million over the past 1 year. A total of 18.99% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SLNO stock. A new stake in Soleno Therapeutics Inc shares was purchased by PERCEPTIVE ADVISORS LLC during the first quarter worth $45,634,000. VISIONPOINT ADVISORY GROUP, LLC invested $3,000 in shares of SLNO during the first quarter. In total, there are 24 active investors with 38.99% ownership of the company’s stock.
With an opening price of $23.43 on Wednesday morning, Soleno Therapeutics Inc (NASDAQ: SLNO) set off the trading day. During the past 12 months, Soleno Therapeutics Inc has had a low of $0.85 and a high of $30.30. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 2.33, and a quick ratio of 2.33. The fifty day moving average price for SLNO is $5.41 and a two-hundred day moving average price translates $3.76 for the stock.
The latest earnings results from Soleno Therapeutics Inc (NASDAQ: SLNO) was released for Jun, 2023.
